In 2023, Moderna started a phase 1/2 study of an experimental pandemic influenzavaccines collectively known as mRNA-1018, which are designed to provide protection against H5 and H7 avian ...
Scientists have now deciphered the structure of the avianinfluenza virus's ... Aug. 15, 2024 — A unique influenzavaccine candidate that's inhaled appears safe and could bolster protection ...